Research & Development: Page 42
-
PharmaVoice Team/PharmaVoice
What's New
Ogilvy CommonHealth Worldwide Acquires Element Marketing Group TrendIng Now: Ogilvy CommonHealth extends focus on reimbursement and market share challenges. Ogilvy CommonHealth Worldwide, the health behavior experts of Ogilvy & Mather, has acquired Element Marketing Group (EMG), a market acce...
By Ann Grey • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Year in Preview: On the Horizon: Looking Ahead…
Experts from across all sectors of the industry provide their input on the trends in 2015 that will have the biggest impact on the industry, and how they will shape the future of healthcare. For this year’s special Year in Preview issue we took a slightly different tact than in years past. We are...
By Taren Grom • Nov. 15, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotech Pool Dr. Annalisa Jenkins Dimension Therapeutics Names CEO Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, has apppointed Annalisa Jenkins, MBBS, MRCP, CEO. Dr. Jenkins succeeds interim CEO Thomas Beck. Dr. Jenkins brings to Dimensi...
By Ann Grey • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Electronic Health Record: A Focus On Patient Benefits
When we think of the positive impact of electronic health record (EHR) adoption, we often focus on the increased efficiency of the medical practice or additional convenience for healthcare providers (HCPs). We do not often associate those benefits with our most important target: the patient. Curr...
By Eugene Lee • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Embracing Co-Creation to Better Connect
Many patient and caregiver campaigns fail to resonate with their intended audiences. Innovative collaboration methods and co-creation with patients and caregivers can add authenticity to communications and elevate brands. Do you remember the telephone game when you were a kid? One person starts t...
By Dan Bobear • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Transdermal Delivery: Winning Patient Preference
The pharma landscape continues to be crowded and competitive, with more emphasis than ever before on delivering improved patient outcomes at a competitive price. In light of this, pharmaceutical companies must not only deliver products that effectively treat patients’ problems, but also prioritiz...
By Ingrid Blair • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Patient Solutions
As healthcare systems begin to pay for outcomes rather than products, patient-centric solutions and services will play a key role in the race to capture value. From wearables to improved drug delivery devices, from apps to EHR platforms, from patient trackers to packaging, the number of solution...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Vested Outsourcing Imperative
Managing the Talent Supply Chain Large life sciences companies today face many challenges in acquiring and managing talent to meet their business imperatives. The first decision to be made is always the same, whether the workforce contains full-time employees, contingent workers, independent cont...
By Kevin D. Duffy • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Supply Chain: Talent Management: A Different Supply Chain Issue
A sound workforce strategy furthers a company’s business agenda and generates results. When the topic of supply chain management is discussed, the conversation typically is about manufacturing and distribution issues. But today one of the most pressing challenges facing CEOs is the talent supply ...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Colombia Emerges as an Attractive Pharma Market
With a growing interest in attracting R&D and continual economic growth, Colombia is seen as an attractive market for pharmaceutical companies. The Republic of Colombia is evolving from an emerging economy, having enjoyed an economic turnaround since 2000, when it was perceived by economists ...
By Kim Ribbink • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Education of Principal Investigators
Efforts by pharma companies and other organizations aim to standardize GCP and training requirements for clinical research investigators and sites. Principal investigators and clinical sites are the backbone of clinical research. Sponsors and CROs depend on investigators and sites to conduct stud...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
New Models for Academic Partnerships
Academic medical centers have a renewed interest in partnering with pharmaceutical companies and are investing resources to ensure successful collaborations. Industry partnerships with universities are changing. These collaborations are no longer about single projects. They are broader in scope, ...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Nanomedicine Revolution
Nanomedicines have the potential to improve effectiveness and reduce the side effects of therapeutics. Nanotechnology has the potential to revolutionize healthcare across disciplines and specialties. For medicines specifically, nanotechnology can improve drug targeting and effectiveness and reduc...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool SCOTT HUNTER Shire Names Marketing Director of Ophthalmics Business Scott Hunter has been appointed as marketing director of the newly formed ophthalmics business at Shire. Mr. Hunter brings more than 12 years of eye care industry experience focused on therapies spanning ocular inflam...
By PharmaVoice Team • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D?Trends affecting the healthcare industry U.S. Pharmaceuticals Market is Improving Trending now: Patient access is broadening with implementation of the Affordable Care Act and the expansion of Medicaid. The outlook for the pharmaceutical market in the United States i...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-Based Applications, Sites, and Technologies IMS Health Introduces Cloud-Based Sales Solution Trending Now: New solution combines territory-specific intelligence, advanced performance analytics, and innovative mobility features. IMS Health has launched the U.S. version of Ne...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Coalition Aims to Help Prevent Abuse and Diversion of ADHD medications Trending Now: Industry stakeholders band together to address medication misuse. The Coalition to Prevent ADHD Medication Misuse (CPAMM) was formed to prevent the misuse, abuse, and diversion of ADHD prescription stimulant medi...
By Ann Grey • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Reinvented Clinical Data Manager
A successful career in clinical data management is more rewarding — and more challenging — than ever before. Incumbents and those aspiring to the job must not only be technically proficient, but must also be strong communicators, project managers, and critical thinkers. While technological ad...
By Eboni Russell • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Digital Patients: Disrupting the Status Quo
Patients have the power of digital technology to fuel their quest for better health, which is forcing the industry to keep pace with their digital needs. Patients’ prolific use of digital technologies to improve their health outcomes is driving other healthcare stakeholders — physicians, payers, ...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool DR. JOHN ORLOFF Baxter Appoints VP of BioScience R&D Baxter International has appointed John Orloff, M.D., as VP and global head of research and development for Baxter BioScience. Dr. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global head of clinical...
By Ann Grey • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
Now in its ninth year, the Site Solutions Summit is dedicated exclusively to helping clinical research sites reach optimal performance. With a foundation built on strengthening the site through industry partnership, the Summit has grown to be a community dedicated to driving clinical research suc...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Social Buzz
A collection of social media news, events, and strategies. Trending now: Mobile technology improves patient outcomes. A randomized control trial conducted through the Montefiore Medical Center earlier this year found a significant improvement in a number of key patient engagement metrics when car...
By Taren Grom • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry Prescription Drug Misuse Trending now: A three-year analysis of more than 1.4 million drug test results shows majority of Americans continue to put health at risk through dangerous drug combinations and skipping doses. Five s...
By Denise Myshko • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
BIO Launches BizLink Trending Now: New resource connects biotech and pharma companies with service providers. The Biotechnology Industry Organization (BIO) has launched BIO BizLink. Powered by OnDeckBiotech, BIO BizLink is positioned to become the industry’s leading resource for connecting biotec...
By Denise Myshko • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies Virtual Library of Deprioritized Compounts Part of Unique Partnership U.K. researchers have access to compounds through a new partnership between the Medical Research Council (MRC) and seven global drug companies. AstraZeneca, GlaxoSmithKli...
By Ann Grey • Aug. 28, 2014
Previous
